SOPHiA GENETICS SA (SOPH), a health technology firm focused on data-driven precision medicine, announced on Monday an expansion of its partnership with AstraZeneca PLC (AZN).
Through this partnership, the companies intend to improve the diagnosis and treatment of breast and prostate cancers by developing an optimized next-generation sequencing (NGS) solution that utilizes SOPHiA GENETICS' AI-driven algorithms.
As part of the deal, SOPHiA GENETICS will introduce a Privileged Access Program for select breast and prostate cancer laboratories to validate performance in real-world settings, with full commercial rollout anticipated in 2026 alongside a multi-center real-world evidence study.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.